Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38371
CAS Number:
107753-78-6
Zafirlukast
Purity:
≥ 98% (HPLC)
Synonym(s):
CyclopentylN-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate, N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamicacid cyclopentyl ester
Documents
$48.27 /100MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Zafirlukast is a potent leukotriene receptor antagonist primarily used in the management of asthma and allergic rhinitis. This compound works by inhibiting the action of leukotrienes, which are inflammatory mediators that contribute to bronchoconstriction and airway inflammation. By blocking these receptors, Zafirlukast helps to improve lung function, reduce the frequency of asthma attacks, and enhance overall respiratory health. Its unique structure allows for effective binding to the cysteinyl leukotriene receptor, making it a valuable option for patients seeking relief from asthma symptoms.

In addition to its primary use in respiratory conditions, Zafirlukast has shown potential in various research applications, including studies on inflammation and allergic responses. Its ability to modulate immune responses makes it a candidate for further exploration in therapeutic areas beyond asthma. Researchers and healthcare professionals appreciate Zafirlukast for its targeted action and favorable safety profile compared to other treatments, making it a preferred choice in personalized asthma management strategies.

Synonyms
CyclopentylN-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate, N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamicacid cyclopentyl ester
CAS Number
107753-78-6
Purity
≥ 98% (HPLC)
Molecular Formula
C31H33N3O6S
Molecular Weight
575.68
MDL Number
MFCD00864775
PubChem ID
5717
Appearance
White to gray to brown powder to crystaline
Conditions
Store at 2 - 8 °C
General Information
Synonyms
CyclopentylN-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate, N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamicacid cyclopentyl ester
CAS Number
107753-78-6
Purity
≥ 98% (HPLC)
Molecular Formula
C31H33N3O6S
Molecular Weight
575.68
MDL Number
MFCD00864775
PubChem ID
5717
Appearance
White to gray to brown powder to crystaline
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Zafirlukast is widely utilized in research focused on:

  • Asthma Management: This compound is primarily used as a leukotriene receptor antagonist, helping to reduce inflammation and bronchoconstriction in asthma patients, thereby improving their breathing and overall quality of life.
  • Allergy Treatment: It is effective in managing allergic rhinitis symptoms, providing relief from nasal congestion and other allergy-related issues, making it a valuable option for individuals suffering from seasonal allergies.
  • Clinical Research: Zafirlukast is often studied in clinical trials to evaluate its efficacy in combination therapies for respiratory diseases, offering insights into new treatment protocols and improving patient outcomes.
  • Pharmaceutical Development: The compound serves as a model for developing new drugs targeting similar pathways, aiding researchers in creating more effective treatments for chronic respiratory conditions.
  • Personalized Medicine: Its application in pharmacogenomics allows for tailored treatment plans based on individual patient responses, enhancing therapeutic effectiveness and minimizing side effects.

Citations